Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Vasopeptidase Inhibitors"'
Autor:
Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA. Electronic address: milton.packer@baylorhealth.edu., McMurray JJV; British Heart Foundation Cardiovascular Research Center, University of Glasgow, Glasgow, UK.
Publikováno v:
Lancet (London, England) [Lancet] 2017 May 06; Vol. 389 (10081), pp. 1831-1840. Date of Electronic Publication: 2016 Dec 03.
Autor:
Bayes-Genis A; Heart Failure Clinic, Cardiology Service, Department of Medicine, UAB, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet, 08916, Badalona, Barcelona, Spain. abayesgenis@gmail.com.; Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain. abayesgenis@gmail.com., Morant-Talamante N; Novartis Pharmaceuticals, Barcelona, Spain., Lupón J; Heart Failure Clinic, Cardiology Service, Department of Medicine, UAB, Hospital Universitari Germans Trias i Pujol, Carretera del Canyet, 08916, Badalona, Barcelona, Spain.; Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.
Publikováno v:
Current heart failure reports [Curr Heart Fail Rep] 2016 Aug; Vol. 13 (4), pp. 151-7.
Publikováno v:
Current Topics in Medicinal Chemistry. 19:1850-1866
Notwithstanding substantial improvements in diagnosis and treatment, Heart Failure (HF) remains a major disease burden with high prevalence and poor outcomes worldwide. Natriuretic Peptides (NPs) modulate whole cardiovascular system and exhibit multi
Autor:
Neel Jayesh Shah
Publikováno v:
Introduction to Basics of Pharmacology and Toxicology ISBN: 9789813360082
Congestive heart failure (CHF) is a systolic dysfunction of the heart in which the pumping efficiency or ejection fraction reduces and the body responses by compensatory mechanisms. Sympathetic activation and activating the RAAS help in the short run
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0e0168bdc27d5ddd54a0aa1163b1b38
https://doi.org/10.1007/978-981-33-6009-9_26
https://doi.org/10.1007/978-981-33-6009-9_26
Publikováno v:
Journal of Medicinal Chemistry
Neprilysin (NEP) and angiotensin-converting enzyme (ACE) are two key zinc-dependent metallopeptidases in the natriuretic peptide and kinin systems and renin-angiotensin-aldosterone system, respectively. They play an important role in blood pressure r
Publikováno v:
Nephrology (Saint-Petersburg). 22:59-67
The review presents data on the involvement of the system of circulating and renal tissue natriuretic peptides in the mechanism that supports water-salt homeostasis and protects the kidney from damage of various etiologies, as well as the results obt
Publikováno v:
Russian Journal of General Chemistry. 89:844-846
A method of synthesis of 3-thiopropinyl derivatives of 5-oxo-1,3,4-benzothiadiazepine-4-acetic acid, potential antihypertensive drugs, vasopeptidase inhibitors, starting from 2-thiobenzoic acid hydrazide has been elaborated.
Publikováno v:
Clinical Science (London, England : 1979)
This article overviews the natriuretic peptides (NPs) system, its role and the development of NP-based treatment of heart failure (HF).
After its discovery in the early 1980s, the natriuretic peptide (NP) system has been extensively characterize
After its discovery in the early 1980s, the natriuretic peptide (NP) system has been extensively characterize
Autor:
Mark A. Yorek
Publikováno v:
Diabetes. 67
Previously we had shown that a vasopeptidase inhibitor, combination drug containing angiotensin converting enzyme and neprilysin inhibitors, was an effective treatment for diabetes vascular and neural complications. However, once in clinical trials,
Autor:
Emmanuel E. Egom
Publikováno v:
Journal of Cardiovascular Translational Research. 8:149-157
The B-type natriuretic peptide (BNP), a member of the family of vasoactive peptides, has emerged as an important diagnostic, prognostic, and therapeutic tool in patients with heart failure (HF). The rapid incorporation into clinical practice of bioas